Form 4 for ARQT Arcutis Biotherapeutics, Inc.
Accepted 2024-11-19 00:00:00 ET · period of report 2024-11-18 · accession 0001787306-24-000159 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-11-19 | 2024-11-19 | ARQT | Matsuda Masaru | See Remarks | S - Sale | $9.68 | -1,775 | 181.4K | -1.0% | -$17.2K | |
| 2024-11-19 | 2024-11-18 | ARQT | Matsuda Masaru | See Remarks | A - Grant | $0.00 | +4,875 | 183.1K | +3% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-11-19 | S | D | 1,775 | $9.68 | 181,373 | D | — | — | (F2) Pursuant to an automatic sell-to-cover imposed by the terms of the initial grant of the PSUs, the shares were sold upon the vesting of the PSUs solely to cover applicable tax withholdings. (F3) The price reported in Column 4 is a weighted average sale price. The shares were sold in multiple transactions at prices ranging from $9.22 to $10.09, inclusive. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote. |
| 2 | Common | Common Stock | 2024-11-18 | A | A | 4,875 | $0.00 | 183,148 | D | — | — | (F1) Represents the vesting of performance stock units ("PSUs") initially granted on January 3, 2022, that were subject to a performance-based vesting condition. The vesting condition was certified as satisfied on November 18, 2022. The PSUs vest 25% per year on each anniversary of the certification date, subject to the Reporting Person's continued service to the Issuer on such vesting date. |